Nevertheless, upregulation of p62 may serve as an attractive therapeutic target to counteract aging and Parkinson’s disease (PD) to restore/enhance alternative mitophagy pathways in pathological conditions where the PINK1–PARKIN pathway is perturbed. The gene discussed is PINK1; the disease is Parkinson disease.